Natural small molecules regulating the mitophagy pathway counteract the pathogenesis of diabetes and chronic complications
Ye Du,
No information about this author
Junping Zhu,
No information about this author
Shengrui Su
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 16, 2025
Diabetes
mellitus
(DM)
is
a
chronic
metabolic
disorder
marked
by
sustained
hyperglycemia.
These
disturbances
contribute
to
extensive
damage
across
various
tissues
and
organs,
giving
rise
severe
complications
such
as
vision
loss,
kidney
failure,
amputations,
higher
morbidity
mortality
rates.
Furthermore,
DM
imposes
substantial
economic
emotional
burden
on
patients,
families,
healthcare
systems.
Mitophagy,
selective
process
that
targets
the
clearance
of
damaged
or
dysfunctional
mitochondria,
pivotal
for
sustaining
cellular
homeostasis
through
mitochondrial
turnover
recycling.
Emerging
evidence
indicates
mitophagy
acts
key
pathogenic
driver
in
pathogenesis
its
associated
complications.
Natural
small
molecules
are
particularly
attractive
this
regard,
offering
advantages
low
toxicity,
favorable
pharmacokinetic
profiles,
excellent
biocompatibility,
broad
range
biochemical
activities.
This
review
systematically
evaluates
mechanistic
roles
natural
molecules-including
ginsenosides,
resveratrol,
berberine-in
enhancing
restoring
via
activation
core
signaling
pathways
(e.g.,
PINK1/Parkin,
BNIP3/NIX,
FUNDC1).
collectively
ameliorate
pathological
hallmarks
DM,
oxidative
stress,
inflammation,
insulin
resistance.
integration
nanotechnology
with
these
compounds
optimizes
their
bioavailability
tissue-specific
targeting,
thereby
establishing
transformative
therapeutic
platform
management.
Current
demonstrates
modulation
not
only
offers
novel
strategies
but
also
advances
foundation
future
drug
development
targeting
disorders.
Language: Английский
Unravelling the Molecular Footprints of Diabetic Foot Ulcers: In Silico Discovery of Key Protein and MicroRNA Signatures
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 12, 2024
Abstract
Diabetic
foot
ulcers
(DFUs)
present
a
significant
clinical
challenge,
characterized
by
chronic
inflammation
and
impaired
wound
healing.
This
study
employs
Gene
Ontology
(GO)
analysis
to
identify
critical
biological
processes,
molecular
functions,
cellular
components,
pathways
associated
with
DFUs,
aiming
uncover
novel
therapeutic
targets.
The
reveals
enrichment
in
processes
such
as
Positive
Regulation
of
miRNA
Transcription
Transcription,
highlighting
the
crucial
role
microRNAs,
including
hsa-miR-34a-5p,
hsa-miR-155-5p,
hsa-miR-17-5p,
hsa-miR-29b-3p,
hsa-miR-7-5p,
hsa-miR-1-3p,
hsa-miR-23b-3p,
regulating
healing
inflammation.
Enriched
DNA-binding
Activator
Activity
Protein
Phosphatase
Binding,
suggest
that
targeting
genes
like
TP53,
GAPDH,
AKT1,
MYC,
TNF,
EGFR,
STAT3,
FN1,
VEGFA,
JUN
could
modulate
improve
DFU
management.
also
identifies
key
Vesicle
Platelet
Alpha
Granule
Lumen,
for
transport
signaling,
suggesting
interventions
these
components
enhance
repair.
Furthermore,
enriched
Proteoglycans
Cancer
Human
Cytomegalovirus
Infection
indicate
potential
mechanisms
viral
influences
relevant
DFUs.
These
findings
provide
comprehensive
framework
developing
targeted
therapies
address
multifaceted
pathology
offering
promising
avenues
improving
patient
outcomes
advancing
strategies.
Language: Английский
Adipose mesenchymal stem cell-derived extracellular vesicles regulate PINK1/parkin-mediated mitophagy to repair high glucose-induced dermal fibroblast senescence and promote wound healing in rats with diabetic foot ulcer
Yanyan Luo,
No information about this author
Qi-Jie Guo,
No information about this author
Chang Liu
No information about this author
et al.
Acta Diabetologica,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 16, 2024
Language: Английский
Mitophagy related diagnostic biomarkers for coronary in-stent restenosis identified using machine learning and bioinformatics
Ming Shen,
No information about this author
Meixian Chen,
No information about this author
Yu Chen
No information about this author
et al.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Oct. 15, 2024
Percutaneous
coronary
intervention
(PCI)
combined
with
stent
implantation
is
currently
one
of
the
most
effective
treatments
for
artery
disease
(CAD).
However,
in-stent
restenosis
(ISR)
significantly
compromises
its
long-term
efficacy.
Mitophagy
plays
a
crucial
role
in
vascular
homeostasis,
yet
ISR
remains
unclear.
This
study
aims
to
identify
mitophagy-related
biomarkers
and
explore
their
underlying
molecular
mechanisms.
Through
differential
gene
expression
analysis
between
Control
samples
dataset,
169
differentially
expressed
genes
(DEGs)
were
identified.
Twenty-three
(DEMRGs)
identified
by
intersecting
(MRGs)
from
GeneCards,
functional
enrichment
indicated
significant
involvement
biological
processes.
Using
Weighted
Gene
Co-expression
Network
Analysis
(WGCNA)
three
machine
learning
algorithms
(Logistic-LASSO,
RF,
SVM-RFE),
LRRK2,
ANKRD13A
as
ISR.
The
nomogram
based
on
these
two
also
exhibited
promising
diagnostic
performance
Set
Enrichment
(GSEA)
well
immune
infiltration
analyses
showed
that
closely
associated
inflammatory
responses
Furthermore,
potential
small
molecule
compounds
therapeutic
implications
predicted
using
connectivity
Map
(cMAP)
database.
systematically
investigated
functions,
providing
new
insights
into
early
diagnosis
precision
treatment
strategies
Language: Английский